Topic
Androgen Deprivation Therapy (ADT)
3 Podcasts on BackTable
Hear how experienced physicians approach Androgen Deprivation Therapy (ADT) on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering patient selection, workup, and procedure technique. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 259 • 09 Sept 2025
Prostate Tumor Board: Risk Stratification & Treatment Strategies
Could ongoing trials redefine the management of oligometastatic and advanced prostate cancer? In this installment of BackTable Tumor Board, leading prostate cancer experts Dr. Neeraj Agarwal, a medical oncologist from the University of Utah, and Dr. Tyler Seibert, a radiation oncologist from UC San Diego, join host Dr. Parth Modi to share their insights on the latest clinical trials and persistent challenges in managing prostate cancer.
More on Androgen Deprivation Therapy (ADT)
Loading recent podcasts…
Urology Episode #259
Sep 9, 2025
with Dr. Parth Modi, Dr. Neeraj Agarwal, Dr. Tyler Seibert
Could ongoing trials redefine the management of oligometastatic and advanced prostate cancer? In this installment of...
2,100+ listens
Urology Episode #210
Jan 21, 2025
with Dr. Rana McKay, Dr. Aditya Bagrodia
What is the role of androgen deprivation therapy (ADT) in prostate cancer treatment? In this episode of the BackTable...
2,100+ listens
Tumor Board Episode #21
Aug 19, 2025
with Dr. Parth Modi, Dr. Neeraj Agarwal, Dr. Tyler Seibert
Could ongoing trials redefine the management of oligometastatic and advanced prostate cancer? In this installment of...
2,100+ listens
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.